Skip to main content
Erschienen in: Current Cardiology Reports 2/2012

01.04.2012 | Nuclear Cardiology (V Dilsizian, Section Editor)

Multimodality Imaging for Assessment of Myocardial Viability: Nuclear, Echocardiography, MR, and CT

verfasst von: James A. Arrighi, Vasken Dilsizian

Erschienen in: Current Cardiology Reports | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The assessment of myocardial viability may be an important component of the evaluation of patients with coronary artery disease and left ventricular dysfunction. The primary goal of viability assessment in such patients is to guide therapeutic decisions by determining which patients would most likely benefit from revascularization. In patients with chronic coronary artery disease, left ventricular dysfunction may be a consequence of prior myocardium infarction, which is an irreversible condition, or reversible ischemic states such as stunning and hibernation. Imaging techniques utilize several methods to assess myocardial viability: left ventricular function, morphology, perfusion, and metabolism. Each technique (echocardiography, nuclear imaging, magnetic resonance imaging, and x-ray computed tomography) has the ability to assess one or more of these parameters. This article describes how each of these imaging modalities can be used to assess myocardial viability, and reviews the relative strengths and limitations of each technique.
Literatur
1.
Zurück zum Zitat Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990;323:141–6.PubMedCrossRef Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990;323:141–6.PubMedCrossRef
2.
Zurück zum Zitat Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630–41.PubMed Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630–41.PubMed
3.
Zurück zum Zitat Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.[see comment]. Circulation. 1991;83:26–37.PubMed Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.[see comment]. Circulation. 1991;83:26–37.PubMed
4.
Zurück zum Zitat Perrone-Filardi P, Pace L, Prastaro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography.[see comment]. Circulation. 1996;94:2712–9.PubMed Perrone-Filardi P, Pace L, Prastaro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography.[see comment]. Circulation. 1996;94:2712–9.PubMed
5.
Zurück zum Zitat Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation. 1994;89:2552–61.PubMed Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation. 1994;89:2552–61.PubMed
6.
Zurück zum Zitat Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol. 2002;9:454–62.PubMedCrossRef Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol. 2002;9:454–62.PubMedCrossRef
7.
Zurück zum Zitat Leoncini M, Sciagra R, Bellandi F, et al. Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy. J Nucl Cardiol. 2002;9:402–6.PubMedCrossRef Leoncini M, Sciagra R, Bellandi F, et al. Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy. J Nucl Cardiol. 2002;9:402–6.PubMedCrossRef
8.
Zurück zum Zitat Gould KL, Yoshida K, Hess MJ, et al. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in manby PET. J Nucl Med. 1991;32:1–9.PubMed Gould KL, Yoshida K, Hess MJ, et al. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in manby PET. J Nucl Med. 1991;32:1–9.PubMed
9.
Zurück zum Zitat Kitsiou AN, Bacharach SL, Bartlett ML, et al. 13N-Ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol. 1999;33:678–86.PubMedCrossRef Kitsiou AN, Bacharach SL, Bartlett ML, et al. 13N-Ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol. 1999;33:678–86.PubMedCrossRef
10.
Zurück zum Zitat Dilsizian V, Bacharach SL, Beanlands SR, Bergmann SR, Delbeke D, Fischman AJ, Gropler RJ, Knuuti J, Schelbert H, Travin M. ASNC imaging guidelines for nuclear cardiology procedures: PET myocardial perfusion and metabolism clinical imaging. J Nucl Card. 2009;16(4):651. doi:10.1007/s12350-009-9094-9. ISSN 1532–6551 (Online).CrossRef Dilsizian V, Bacharach SL, Beanlands SR, Bergmann SR, Delbeke D, Fischman AJ, Gropler RJ, Knuuti J, Schelbert H, Travin M. ASNC imaging guidelines for nuclear cardiology procedures: PET myocardial perfusion and metabolism clinical imaging. J Nucl Card. 2009;16(4):651. doi:10.​1007/​s12350-009-9094-9. ISSN 1532–6551 (Online).CrossRef
11.
Zurück zum Zitat Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884–8.PubMedCrossRef Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884–8.PubMedCrossRef
12.
Zurück zum Zitat vom Dahl J, Eitzman DT, al-Aouar ZR, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation. 1994;90:2356–66.PubMed vom Dahl J, Eitzman DT, al-Aouar ZR, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation. 1994;90:2356–66.PubMed
13.
Zurück zum Zitat Srinivasan G, Kitsiou AN, Bacharach SL, Bartlett ML, Miller-Davis C, Dilsizian V. 18F-fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation. 1998;97:843–50.PubMed Srinivasan G, Kitsiou AN, Bacharach SL, Bartlett ML, Miller-Davis C, Dilsizian V. 18F-fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation. 1998;97:843–50.PubMed
14.
Zurück zum Zitat Marin-Neto JA, Dilsizian V, Arrighi JA, Perrone-Filardi P, Bacharach SL, Bonow RO. Thallium scintigraphy compared with 18F-fluorodeoxyglucose Positron Emission Tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction. Am J Cardiol. 1998;82:1001–7.PubMedCrossRef Marin-Neto JA, Dilsizian V, Arrighi JA, Perrone-Filardi P, Bacharach SL, Bonow RO. Thallium scintigraphy compared with 18F-fluorodeoxyglucose Positron Emission Tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction. Am J Cardiol. 1998;82:1001–7.PubMedCrossRef
15.
Zurück zum Zitat Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram M, Goodbody AE, Babich JW, Udelson JE. Metabolic imaging with β-methyl-ρ-[123I]-iodophenyl-pentadecanoic acid (BMIPP) identifies ischemic memory following demand ischemia. Circulation. 2005;112(14):2169–74.PubMedCrossRef Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram M, Goodbody AE, Babich JW, Udelson JE. Metabolic imaging with β-methyl-ρ-[123I]-iodophenyl-pentadecanoic acid (BMIPP) identifies ischemic memory following demand ischemia. Circulation. 2005;112(14):2169–74.PubMedCrossRef
16.
Zurück zum Zitat Taegtmeyer H, Dilsizian V. Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Card. 2008;5:S42–8.CrossRef Taegtmeyer H, Dilsizian V. Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Card. 2008;5:S42–8.CrossRef
17.
Zurück zum Zitat Dilsizian V. FDG uptake as a surrogate marker for antecedent ischemia. J Nucl Med. 2008;49(12):1909–11.PubMedCrossRef Dilsizian V. FDG uptake as a surrogate marker for antecedent ischemia. J Nucl Med. 2008;49(12):1909–11.PubMedCrossRef
18.
Zurück zum Zitat Franken PR, Hambye AS, De Geeter FW. BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction. Int J Card Imag. 1999;15:27–34.CrossRef Franken PR, Hambye AS, De Geeter FW. BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction. Int J Card Imag. 1999;15:27–34.CrossRef
19.
Zurück zum Zitat Chen C, Li L, Chen LL, et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation. 1995;92:756–66.PubMed Chen C, Li L, Chen LL, et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation. 1995;92:756–66.PubMed
20.
Zurück zum Zitat Cornel JH, Bax JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol. 1998;31:1002–10.PubMedCrossRef Cornel JH, Bax JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol. 1998;31:1002–10.PubMedCrossRef
21.
Zurück zum Zitat Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663–70.PubMed Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663–70.PubMed
22.
Zurück zum Zitat Dilsizian V. Myocardial viability: contractile reserve or cell membrane integrity? J Am Coll Cardiol. 1996;28:443–6.PubMedCrossRef Dilsizian V. Myocardial viability: contractile reserve or cell membrane integrity? J Am Coll Cardiol. 1996;28:443–6.PubMedCrossRef
23.
Zurück zum Zitat Arrighi JA, Dilsizian V. Assessment of myocardial viability by radionuclide and echocardiographic techniques: is it simply a sensitivity and specificity issue? Curr Opin Cardiol. 2006;21(5):450–6.PubMedCrossRef Arrighi JA, Dilsizian V. Assessment of myocardial viability by radionuclide and echocardiographic techniques: is it simply a sensitivity and specificity issue? Curr Opin Cardiol. 2006;21(5):450–6.PubMedCrossRef
24.
Zurück zum Zitat Baumgartner H, Porenta G, Lau YK, et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol. 1998;32:1701–8.PubMedCrossRef Baumgartner H, Porenta G, Lau YK, et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol. 1998;32:1701–8.PubMedCrossRef
25.
Zurück zum Zitat Poldermans D, Sozzi FB, Bax JJ, et al. Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. Am J Cardiol. 2001;88:A7.PubMed Poldermans D, Sozzi FB, Bax JJ, et al. Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. Am J Cardiol. 2001;88:A7.PubMed
26.
Zurück zum Zitat Piscione F, Perrone-Filardi P, De Luca G, et al. Low dose dobutamine echocardiography for predicting functional recovery after coronary revascularisation. Heart. 2001;86:679–86.PubMedCrossRef Piscione F, Perrone-Filardi P, De Luca G, et al. Low dose dobutamine echocardiography for predicting functional recovery after coronary revascularisation. Heart. 2001;86:679–86.PubMedCrossRef
27.
Zurück zum Zitat Shimoni S, Frangogiannis NG, Aggeli CJ, et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation. 2003;107:538–44.PubMedCrossRef Shimoni S, Frangogiannis NG, Aggeli CJ, et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation. 2003;107:538–44.PubMedCrossRef
28.
Zurück zum Zitat Penicka M, Tousek P, De Bruyne B, et al. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. Eur Hear J. 2007;28:1366–73.CrossRef Penicka M, Tousek P, De Bruyne B, et al. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. Eur Hear J. 2007;28:1366–73.CrossRef
29.
Zurück zum Zitat Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Society for cardiovascular magnetic resonance board of trustees task force on standardized P. standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.PubMedCrossRef Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Society for cardiovascular magnetic resonance board of trustees task force on standardized P. standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.PubMedCrossRef
30.
Zurück zum Zitat Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. 2004;109:2172–4.PubMedCrossRef Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. 2004;109:2172–4.PubMedCrossRef
31.
Zurück zum Zitat Ramani K, Judd RM, Holly TA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation. 1998;98:2687–94.PubMed Ramani K, Judd RM, Holly TA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation. 1998;98:2687–94.PubMed
32.
Zurück zum Zitat Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110:1535–41.PubMedCrossRef Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110:1535–41.PubMedCrossRef
33.
Zurück zum Zitat Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21–8.PubMedCrossRef Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21–8.PubMedCrossRef
34.
Zurück zum Zitat Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53.PubMedCrossRef Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53.PubMedCrossRef
35.
Zurück zum Zitat Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101–7.PubMedCrossRef Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101–7.PubMedCrossRef
36.
Zurück zum Zitat Dilsizian V. Cardiac magnetic resonance versus SPECT: are all non-infarct myocardial regions created equal? J Nucl Card. 2007;14(1):9–14.CrossRef Dilsizian V. Cardiac magnetic resonance versus SPECT: are all non-infarct myocardial regions created equal? J Nucl Card. 2007;14(1):9–14.CrossRef
37.
Zurück zum Zitat • Mendoza DD, Joshi SB, Weissman G, Taylor AJ, Weigold WG. Viability imaging by cardiac computed tomography. J Cardiovasc Comput Tomogr. 2010;4:83–91. This is a concise review that summarizes how cardiac CT imaging, an emerging technology, can be used for the assessment of myocardial viability.PubMedCrossRef • Mendoza DD, Joshi SB, Weissman G, Taylor AJ, Weigold WG. Viability imaging by cardiac computed tomography. J Cardiovasc Comput Tomogr. 2010;4:83–91. This is a concise review that summarizes how cardiac CT imaging, an emerging technology, can be used for the assessment of myocardial viability.PubMedCrossRef
38.
Zurück zum Zitat Rodriguez-Granillo GA, Rosales MA, Baum S, et al. Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention. JACC: Cardiovasc Imag. 2009;2:1072–81.CrossRef Rodriguez-Granillo GA, Rosales MA, Baum S, et al. Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention. JACC: Cardiovasc Imag. 2009;2:1072–81.CrossRef
39.
Zurück zum Zitat Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJ. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298–304.PubMed Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJ. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298–304.PubMed
40.
Zurück zum Zitat Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.[see comment]. J Am Coll Cardiol. 2002;39:1151–8.PubMedCrossRef Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.[see comment]. J Am Coll Cardiol. 2002;39:1151–8.PubMedCrossRef
41.
Zurück zum Zitat • Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607–16. This paper presents results of the STICH trial, in which over 1200 patients were randomized into two treatment arms: medical therapy alone versus medical therapy plus coronary bypass surgery.PubMedCrossRef • Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607–16. This paper presents results of the STICH trial, in which over 1200 patients were randomized into two treatment arms: medical therapy alone versus medical therapy plus coronary bypass surgery.PubMedCrossRef
42.
Zurück zum Zitat • Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25. This paper presents results of the myocardial viability substudy from the STICH trial.PubMedCrossRef • Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25. This paper presents results of the myocardial viability substudy from the STICH trial.PubMedCrossRef
43.
Zurück zum Zitat Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995;92:3436–44.PubMed Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995;92:3436–44.PubMed
44.
Zurück zum Zitat Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol. 1992;69:854–9.PubMedCrossRef Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol. 1992;69:854–9.PubMedCrossRef
45.
Zurück zum Zitat Di Carli M, Sherman T, Khanna S, et al. Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:860–8.PubMedCrossRef Di Carli M, Sherman T, Khanna S, et al. Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:860–8.PubMedCrossRef
46.
Zurück zum Zitat Eitzman D, al-Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.[see comment]. J Am Coll Cardiol. 1992;20:559–65.PubMedCrossRef Eitzman D, al-Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.[see comment]. J Am Coll Cardiol. 1992;20:559–65.PubMedCrossRef
47.
Zurück zum Zitat Rohatgi R, Epstein S, Henriquez J, et al. Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction. Am J Cardiol. 2001;87:1096–9.PubMedCrossRef Rohatgi R, Epstein S, Henriquez J, et al. Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction. Am J Cardiol. 2001;87:1096–9.PubMedCrossRef
48.
Zurück zum Zitat Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Rokhsar S, Maddahi J. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.[see comment]. J Nucl Cardiol. 1998;5:558–66.PubMedCrossRef Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Rokhsar S, Maddahi J. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.[see comment]. J Nucl Cardiol. 1998;5:558–66.PubMedCrossRef
49.
Zurück zum Zitat Bigi R, Desideri A, Bax JJ, et al. Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. Am J Cardiol. 2001;87:283–8.PubMedCrossRef Bigi R, Desideri A, Bax JJ, et al. Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. Am J Cardiol. 2001;87:283–8.PubMedCrossRef
50.
Zurück zum Zitat Gioia G, Milan E, Giubbini R, DePace N, Heo J, Iskandrian AS. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol. 1996;3:150–6.PubMedCrossRef Gioia G, Milan E, Giubbini R, DePace N, Heo J, Iskandrian AS. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol. 1996;3:150–6.PubMedCrossRef
51.
Zurück zum Zitat Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96:793–800.PubMed Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96:793–800.PubMed
52.
Zurück zum Zitat Siebelink HM, Blanksma PK, Crijns HJ, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol. 2001;37:81–8.PubMedCrossRef Siebelink HM, Blanksma PK, Crijns HJ, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol. 2001;37:81–8.PubMedCrossRef
53.
Zurück zum Zitat Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.[see comment]. J Am Coll Cardiol. 1997;30:1693–700.PubMedCrossRef Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.[see comment]. J Am Coll Cardiol. 1997;30:1693–700.PubMedCrossRef
54.
Zurück zum Zitat Beanlands RSB, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).[see comment]. J Am Coll Cardiol. 2007;50:2002–12.PubMedCrossRef Beanlands RSB, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).[see comment]. J Am Coll Cardiol. 2007;50:2002–12.PubMedCrossRef
55.
Zurück zum Zitat • D’Egidio G, Nichol G, Williams KA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. Jacc: Cardiovasc Imag. 2009;2:1060–8. In this substudy of the PPAR-2 trial, a significant interaction was found between PET viability study findings and outcome after revascularization, suggesting that PET viability imaging may be useful in many patients with ischemic cardiomyopathy.CrossRef • D’Egidio G, Nichol G, Williams KA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. Jacc: Cardiovasc Imag. 2009;2:1060–8. In this substudy of the PPAR-2 trial, a significant interaction was found between PET viability study findings and outcome after revascularization, suggesting that PET viability imaging may be useful in many patients with ischemic cardiomyopathy.CrossRef
56.
Zurück zum Zitat Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol. 1998;32:921–6.PubMedCrossRef Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol. 1998;32:921–6.PubMedCrossRef
57.
Zurück zum Zitat Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 1999;34:730–8.PubMedCrossRef Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 1999;34:730–8.PubMedCrossRef
58.
Zurück zum Zitat Schinkel AFL, Poldermans D, Elhendy A, Bax JJ. Prognostic role of dobutamine stress echocardiography in myocardial viability. Curr Opin Cardiol. 2006;21:443–9.PubMedCrossRef Schinkel AFL, Poldermans D, Elhendy A, Bax JJ. Prognostic role of dobutamine stress echocardiography in myocardial viability. Curr Opin Cardiol. 2006;21:443–9.PubMedCrossRef
59.
Zurück zum Zitat Kwong RY, Korlakunta H. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Top Magn Reson Imag. 2008;19:15–24.CrossRef Kwong RY, Korlakunta H. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Top Magn Reson Imag. 2008;19:15–24.CrossRef
Metadaten
Titel
Multimodality Imaging for Assessment of Myocardial Viability: Nuclear, Echocardiography, MR, and CT
verfasst von
James A. Arrighi
Vasken Dilsizian
Publikationsdatum
01.04.2012
Verlag
Current Science Inc.
Erschienen in
Current Cardiology Reports / Ausgabe 2/2012
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-011-0242-x

Weitere Artikel der Ausgabe 2/2012

Current Cardiology Reports 2/2012 Zur Ausgabe

Valvular Heart Disease (V Nkomo, Section Editor)

Ischemic Mitral Regurgitation: Not Only a Bystander

Valvular Heart Disease (V Nkomo, Section Editor)

Minimally Invasive Heart Valve Surgery: How and Why in 2012

Valvular Heart Disease (V Nkomo, Section Editor)

Tricuspid Regurgitation: Pathophysiology and Management

Peripheral Vascular Disease (M Shishehbor, Section Editor)

Current Endovascular Management of Abdominal Aortic Aneurysm

Peripheral Vascular Disease (M Shishehbor, Section Editor)

Renal Intervention to Treat Hypertension

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.